All Guidelines

Displaying 81 - 100 out of 212 guidelines found

  1. Efficacy of Transcutaneous Electric Nerve Stimulation in the Treatment of Pain in Neurologic Disorders

    January 2010

    Current guideline. Reaffirmed on January 24, 2015, and January 20, 2018.

  2. Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy

    January 2010

    Current guideline. Reaffirmed on July 13, 2013.

  3. Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Drug, Nutritional, and Respiratory Therapies

    October 2009

    Current guideline. Reaffirmed on April 30, 2014. Endorsed by the American Association of Neuromuscular and Electrodiagnostic Medicine.

  4. Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Management, and Cognitive/Behavioral Impairment

    October 2009

    Current guideline. Reaffirmed on April 30, 2014. Endorsed by the American Association of Neuromuscular and Electrodiagnostic Medicine.

  5. Evaluation of the Child with Microcephaly

    September 2009

    Current guideline. Reaffirmed on July 13, 2013, and on January 23, 2016. Access a video demonstration on taking head measurements.

  6. Update: Management Issues for Women with Epilepsy-Focus on Pregnancy: Obstetrical Complications and Change in Seizure Frequency

    July 2009

    Update in progress. Reaffirmed on July 13, 2013.

  7. Update: Management Issues for Women with Epilepsy-Focus on Pregnancy: Teratogenesis and Perinatal Outcomes

    July 2009

    Update in progress. Reaffirmed on July 13, 2013.

  8. Update: Management Issues for Women with Epilepsy-Focus on Pregnancy: Vitamin K, Folic Acid, Blood Levels, and Breastfeeding

    July 2009

    Update in progress. Reaffirmed on July 13, 2013.

  9. Clinical Practice Guideline: Hoarseness (Dysphonia)

    June 2009

    Developed by the American Academy of Otolaryngology - Head and Neck Surgery Foundation.

  10. Definition and Evaluation of Transient Ischemic Attack

    May 2009

    Guideline from the American Heart /American Stroke Association. Affirmed by the AAN on March 11, 2009.

  11. A Review of the Evidence for the Use of Telemedicine Within Stroke Systems of Care

    May 2009

    Guideline from the American Heart Association/American Stroke Association. Affirmed by the AAN on March 11, 2009.

  12. Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention. A Call for Completion of Randomized Clinical Trials

    May 2009

    Developed by the American College of Cardiology Foundation, the American Heart Association, and the American Stroke Association. Affirmed by the AAN on March 11, 2009.

  13. Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator: A Science Advisory From the American Heart Association/American Stroke Association

    May 2009

    Guideline from the American Heart Association/American Stroke Association. Affirmed by the AAN on October 5, 2009.

  14. Evaluation of Distal Symmetric Polyneuropathy: Role of Laboratory and Genetic Testing

    January 2009

    Update in progress. Reaffirmed on July 13, 2013.

  15. Evaluation of Distal Symmetric Polyneuropathy: Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy

    January 2009

    Current guideline. Reaffirmed on July 13, 2013 and April 19, 2016.

  16. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Statement for Healthcare Professionals

    January 2009

    Guideline from the American Heart Association/American Stroke Association. Affirmed by the AAN on March 11, 2009.

  17. The Diagnostic Evaluation and Treatment of Trigeminal Neuralgia

    October 2008

    Update in progress. Reaffirmed on April 30, 2014.

  18. The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis

    September 2008

    Retired guideline.

  19. Botulinum Neurotoxin for the Treatment of Movement Disorders

    May 2008

    Under update. Endorsed by the American Association of Neuromuscular & Electrodiagnostic Medicine and the American Academy of Physical Medicine & Rehabilitation.

  20. Botulinum Neurotoxin for the Treatment of Spasticity

    May 2008

    Update in progress. Endorsed by the American Academy of Physical Medicine & Rehabilitation and the American Association of Neuromuscular & Electrodiagnostic Medicine.

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer